Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Eledon Pharmaceuticals (ELDN) Equity Ratio (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Equity Ratio readings, the most recent being 0.93 for Q4 2017.

  • On a quarterly basis, Equity Ratio rose 141.21% to 0.93 in Q4 2017 year-over-year; TTM through Dec 2017 was 0.93, a 141.21% increase, with the full-year FY2017 number at 0.93, up 141.21% from a year prior.
  • Equity Ratio hit 0.93 in Q4 2017 for Eledon Pharmaceuticals, up from 0.9 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.96 in Q4 2014 to a low of 2.26 in Q4 2016.
  • Median Equity Ratio over the past 5 years was 0.9 (2017), compared with a mean of 0.46.
  • Biggest five-year swings in Equity Ratio: soared 156.12% in 2014 and later plummeted 5620.01% in 2016.
  • Eledon Pharmaceuticals' Equity Ratio stood at 1.71 in 2013, then soared by 156.12% to 0.96 in 2014, then tumbled by 95.74% to 0.04 in 2015, then plummeted by 5620.01% to 2.26 in 2016, then surged by 141.21% to 0.93 in 2017.
  • The last three reported values for Equity Ratio were 0.93 (Q4 2017), 0.9 (Q3 2017), and 0.87 (Q2 2017) per Business Quant data.